Abstract
Although cardiac arrhythmia had long been considered a predominantly male syndrome, it is now clear that arrhythmia is also a primary cause of mortality in women. Notably, the manifestation of specific arrhythmia syndromes appears to be gender specific. In particular, female sex is an independent risk factor for development of torsade de pointes (TdP) arrhythmias not only in congenital long QT syndromes but also in acquired long QT syndromes which occur as adverse effects of existing drugs. Males, on the other hand, are more likely to develop Brugada syndrome. Recent clinical and experimental studies suggest that these differences may stem from intrinsic sex differences in cardiac tissue. These include fundamental electrical differences resulting from variable ion channel expression and diverse sex hormonal regulation via long-term genomic and acute nongenomic pathways, and sex differences in drug responses and metabolisms. Undoubtedly, determining the effect of gender on cardiac function will be difficult and require sophisticated methodologies. However, gender differences underlying predilection to distinct arrhythmia syndromes must be revealed so that new therapeutic strategies that take gender into account can be applied to at-risk patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- TdP:
-
Torsade de pointe(s)
- ECG:
-
Electrocardiograms
- QTC :
-
Rate-corrected QT
- ER:
-
Estrogen receptor
- MAPK:
-
Mitogen-activated protein kinase
- eNOS:
-
Endothelial nitric oxide synthase
- PI3K:
-
Phosphoinositide 3-kinase
- IKs :
-
The slow delayed rectifier K+ current
- ICa,L :
-
L-type Ca2+ current
- hERG:
-
Human ether-a-go-go-related gene
- IKr :
-
The rapid delayed rectifier current
- E2:
-
17β-estradiol
- WPW:
-
Wolff–Parkinson–White
References
Abi-Gerges N, Philp K, Pollard C, Wakefield I, Hammond TG, Valentin JP (2004) Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de Pointes. Fundam Clin Pharmacol 18:139
Abriel H, Schlapfer J, Keller DI, Gavillet B, Buclin T, Biollaz J, Stoller R, Kappenberger L (2004) Molecular and clinical determinants of drug-induced long QT syndrome: an iatrogenic channelopathy. Swiss Med Wkly 134:685
Allan CA, McLachlan RI (2004) Age-related changes in testosterone and the role of replacement therapy in older men. Clin Endocrinol (Oxf) 60:653
Andelfinger G, Tapper AR, Welch RC, Vanoye CG, George AL Jr, Benson DW (2002) KCNJ2 mutation results in Andersen syndrome with sex-specific cardiac and skeletal muscle phenotypes. Am J Hum Genet 71:663
Antzelevitch C (2006) Brugada syndrome. Pacing Clin Electrophysiol 29:1130
Anzenbacher P, Anzenbacherova E (2001) Cytochromes P450 and metabolism of xenobiotics. Cell Mol Life Sci 58:737
Asada K, Kurokawa J, Furukawa T (2009) Redox- and calmodulin-dependent S-nitrosylation of the KCNQ1 channel. J Biol Chem 284:6014
Bai CX, Kurokawa J, Tamagawa M, Nakaya H, Furukawa T (2005) Nontranscriptional regulation of cardiac repolarization currents by testosterone. Circulation 112:1701
Bazett HC (1920) An analysis of the time-relations of electrocardiograms. Heart 7:353
Behl C, Holsboer F (1999) The female sex hormone oestrogen as a neuroprotectant. Trends Pharmacol Sci 20:441
Benito B, Sarkozy A, Mont L, Henkens S, Berruezo A, Tamborero D, Arzamendi D, Berne P, Brugada R, Brugada P, Brugada J (2008) Gender differences in clinical manifestations of Brugada syndrome. J Am Coll Cardiol 52:1567
Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, Wolf PA (1994) Independent risk factors for atrial fibrillation in a population-based cohort, The Framingham Heart Study. JAMA 271:840
Berger F, Borchard U, Hafner D, Putz I, Weis TM (1997) Effects of 17beta-estradiol on action potentials and ionic currents in male rat ventricular myocytes. Naunyn Schmiedebergs Arch Pharmacol 356:788
Bidoggia H, Maciel JP, Capalozza N, Mosca S, Blaksley EJ, Valverde E, Bertran G, Arini P, Biagetti MO, Quinteiro RA (2000) Sex-dependent electrocardiographic pattern of cardiac repolarization. Am Heart J 140:430
Burke JH, Ehlert FA, Kruse JT, Parker MA, Goldberger JJ, Kadish AH (1997) Gender-specific differences in the QT interval and the effect of autonomic tone and menstrual cycle in healthy adults. Am J Cardiol 79:178
Burke JH, Goldberger JJ, Ehlert FA, Kruse JT, Parker MA, Kadish AH (1996) Gender differences in heart rate before and after autonomic blockade: evidence against an intrinsic gender effect. Am J Med 100:537
Carnes CA, Dech SJ (2002) Effects of dihydrotestosterone on cardiac inward rectifier K(+) current. Int J Androl 25:210
Carnethon MR, Anthony MS, Cascio WE, Folsom AR, Rautaharju PM, Liao D, Evans GW, Heiss G (2003) A prospective evaluation of the risk of QT prolongation with hormone replacement therapy: the atherosclerosis risk in communities study. Ann Epidemiol 13:530
Catterall WA, Yu FH (2006) Painful channels. Neuron 52:743
Cheng J (2006) Evidences of the gender-related differences in cardiac repolarization and the underlying mechanisms in different animal species and human. Fundam Clin Pharmacol 20:1
Clancy CE, Kurokawa J, Tateyama M, Wehrens XH, Kass RS (2003) K+ channel structure-activity relationships and mechanisms of drug-induced QT prolongation. Annu Rev Pharmacol Toxicol 43:441
Connolly SJ (2010) Atrial fibrillation in 2010: advances in treatment and management. Nat Rev Cardiol 8:67
Dash R, Frank KF, Carr AN, Moravec CS, Kranias EG (2001) Gender influences on sarcoplasmic reticulum Ca2+ -handling in failing human myocardium. J Mol Cell Cardiol 33:1345
De Caterina R, Hylek EM (2011) Stroke prevention in atrial fibrillation: current status and near-future directions. Am J Med 124:793
Deneke T, Muller P, Lawo T, Lemke B, Horlitz M, Calcum B, Bosche LI, Mugge A, Grewe PH (2009) Gender differences in onset of symptoms in AV nodal re-entrant and accessory pathway-mediated re-entrant tachycardia. Herzschrittmacherther Elektrophysiol 20:33
Dhala A, Underwood D, Leman R, Madu E, Baugh D, Ozawa Y, Kasamaki Y, Xue Q, Reddy S (2002) Signal-averaged P-wave analysis of normal controls and patients with paroxysmal atrial fibrillation: a study in gender differences, age dependence, and reproducibility. Clin Cardiol 25:525
Di Diego JM, Cordeiro JM, Goodrow RJ, Fish JM, Zygmunt AC, Perez GJ, Scornik FS, Antzelevitch C (2002) Ionic and cellular basis for the predominance of the Brugada syndrome phenotype in males. Circulation 106:2004
Dorgan JF, Fears TR, McMahon RP, Aronson Friedman L, Patterson BH, Greenhut SF (2002) Measurement of steroid sex hormones in serum: a comparison of radioimmunoassay and mass spectrometry. Steroids 67:151
Drici MD, Knollmann BC, Wang WX, Woosley RL (1998) Cardiac actions of erythromycin: influence of female sex. JAMA 280:1774
Ebert SN, Liu XK, Woosley RL (1998) Female gender as a risk factor for drug-induced cardiac arrhythmias: evaluation of clinical and experimental evidence. J Womens Health 7:547
Endres S, Mayuga KA, de Cristofaro A, Taneja T, Goldberger JJ, Kadish AH (2006) Age and gender difference in ST height at rest and after double autonomic blockade in normal adults. Ann Noninvasive Electrocardiol 11:253
Escarcega RO, Jimenez-Hernandez M, Garcia-Carrasco M, Perez-Alva JC, Brugada J (2009) The Brugada syndrome. Acta Cardiol 64:795
Farhat MY, Chen MF, Bhatti T, Iqbal A, Cathapermal S, Ramwell PW (1993) Protection by oestradiol against the development of cardiovascular changes associated with monocrotaline pulmonary hypertension in rats. Br J Pharmacol 110:719
Fermini B, Fossa AA (2003) The impact of drug-induced QT interval prolongation on drug discovery and development. Nat Rev Drug Discov 2:439
Fish JM, Antzelevitch C (2003) Cellular and ionic basis for the sex-related difference in the manifestation of the Brugada syndrome and progressive conduction disease phenotypes. J Electrocardiol 36 Suppl:173
Friberg J, Scharling H, Gadsboll N, Jensen GB (2003) Sex-specific increase in the prevalence of atrial fibrillation (The Copenhagen City Heart Study). Am J Cardiol 92:1419
Furukawa T, Kurokawa J (2007) Regulation of cardiac ion channels via non-genomic action of sex steroid hormones: implication for the gender difference in cardiac arrhythmias. Pharmacol Ther 115:106
Gaborit N, Varro A, Le Bouter S, Szuts V, Escande D, Nattel S, Demolombe S (2010) Gender-related differences in ion-channel and transporter subunit expression in non-diseased human hearts. J Mol Cell Cardiol 49:639
Gowda RM, Khan IA, Punukollu G, Vasavada BC, Sacchi TJ, Wilbur SL (2004) Female preponderance in ibutilide-induced torsade de pointes. Int J Cardiol 95:219
Gupte SA, Tateyama M, Okada T, Oka M, Ochi R (2002) Epiandrosterone, a metabolite of testosterone precursor, blocks L-type calcium channels of ventricular myocytes and inhibits myocardial contractility. J Mol Cell Cardiol 34:679
Hansen S, Rasmussen V, Larsen K, Torp-Pedersen C, Jensen GB (2007) Circadian variation in QT dispersion determined from a 12-lead Holter recording: a methodological study of an age- and sex-stratified group of healthy subjects. Ann Noninvasive Electrocardiol 12:185
Hara M, Danilo P Jr, Rosen MR (1998) Effects of gonadal steroids on ventricular repolarization and on the response to E4031. J Pharmacol Exp Ther 285:1068
Haseroth K, Seyffart K, Wehling M, Christ M (2000) Effects of progestin-estrogen replacement therapy on QT-dispersion in postmenopausal women. Int J Cardiol 75:161
Hashimoto K (2007) Arrhythmia models for drug research: classification of antiarrhythmic drugs. J Pharmacol Sci 103:333
Hess DT, Matsumoto A, Kim SO, Marshall HE, Stamler JS (2005) Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol 6:150
Hirshoren N, Tzoran I, Makrienko I, Edoute Y, Plawner MM, Itskovitz-Eldor J, Jacob G (2002) Menstrual cycle effects on the neurohumoral and autonomic nervous systems regulating the cardiovascular system. J Clin Endocrinol Metab 87:1569
Hreiche R, Morissette P, Turgeon J (2008) Drug-induced long QT syndrome in women: review of current evidence and remaining gaps. Gend Med 5:124
Hulot JS, Demolis JL, Riviere R, Strabach S, Christin-Maitre S, Funck-Brentano C (2003) Influence of endogenous oestrogens on QT interval duration. Eur Heart J 24:1663
Improta-Brears T, Whorton AR, Codazzi F, York JD, Meyer T, McDonnell DP (1999) Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. Proc Natl Acad Sci USA 96:4686
Jackman WM, Beckman KJ, McClelland JH, Wang X, Friday KJ, Roman CA, Moulton KP, Twidale N, Hazlitt HA, Prior MI et al (1992) Treatment of supraventricular tachycardia due to atrioventricular nodal reentry, by radiofrequency catheter ablation of slow-pathway conduction. N Engl J Med 327:313
Jaffrey SR, Erdjument-Bromage H, Ferris CD, Tempst P, Snyder SH (2001) Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat Cell Biol 3:193
James AF, Choisy SC, Hancox JC (2007) Recent advances in understanding sex differences in cardiac repolarization. Prog Biophys Mol Biol 94:265
Janse de Jonge XA, Boot CR, Thom JM, Ruell PA, Thompson MW (2001) The influence of menstrual cycle phase on skeletal muscle contractile characteristics in humans. J Physiol 530:161
Kaab S, Schulze-Bahr E (2005) Susceptibility genes and modifiers for cardiac arrhythmias. Cardiovasc Res 67:397
Kadish AH, Greenland P, Limacher MC, Frishman WH, Daugherty SA, Schwartz JB (2004) Estrogen and progestin use and the QT interval in postmenopausal women. Ann Noninvasive Electrocardiol 9:366
Kamakura S, Ohe T, Nakazawa K, Aizawa Y, Shimizu A, Horie M, Ogawa S, Okumura K, Tsuchihashi K, Sugi K, Makita N, Hagiwara N, Inoue H, Atarashi H, Aihara N, Shimizu W, Kurita T, Suyama K, Noda T, Satomi K, Okamura H, Tomoike H (2009) Long-term prognosis of probands with Brugada-pattern ST-elevation in leads V1-V3. Circ Arrhythm Electrophysiol 2:495
Kannel WB, Schatzkin A (1985) Sudden death: lessons from subsets in population studies. J Am Coll Cardiol 5:141B
Kassotis J, Costeas C, Bedi AK, Tolat A, Reiffel J (2000) Effects of aging and gender on QT dispersion in an overtly healthy population. Pacing Clin Electrophysiol 23:1121
Kim JA, Lopes CM, Moss AJ, McNitt S, Barsheshet A, Robinson JL, Zareba W, Ackerman MJ, Kaufman ES, Towbin JA, Vincent M, Goldenberg I (2010) Trigger-specific risk factors and response to therapy in long QT syndrome type 2. Heart Rhythm 7:1797
Kohli P, Gulati M (2010) Exercise stress testing in women: going back to the basics. Circulation 122:2570
Korte T, Fuchs M, Arkudas A, Geertz S, Meyer R, Gardiwal A, Klein G, Niehaus M, Krust A, Chambon P, Drexler H, Fink K, Grohe C (2005) Female mice lacking estrogen receptor beta display prolonged ventricular repolarization and reduced ventricular automaticity after myocardial infarction. Circulation 111:2282
Kurokawa J (2007) Compartmentalized regulations of ion channels in the heart. Biol Pharm Bull 30:2231
Kurokawa J, Abriel H (2009) Neurohormonal regulation of cardiac ion channels in chronic heart failure. J Cardiovasc Pharmacol 54:98
Kurokawa J, Tamagawa M, Harada N, Honda S, Bai CX, Nakaya H, Furukawa T (2008) Acute effects of oestrogen on the guinea pig and human IKr channels and drug-induced prolongation of cardiac repolarization. J Physiol 586:2961
Lahtinen AM, Marjamaa A, Swan H, Kontula K (2011) KCNE1 D85N polymorphism–a sex-specific modifier in type 1 long QT syndrome? BMC Med Genet 12:11
Lehmann MH, Hardy S, Archibald D, Quart B, MacNeil DJ (1996) Sex difference in risk of torsade de pointes with d, l-sotalol. Circulation 94:2535
Lehmann MH, Timothy KW, Frankovich D, Fromm BS, Keating M, Locati EH, Taggart RT, Towbin JA, Moss AJ, Schwartz PJ, Vincent GM (1997) Age-gender influence on the rate-corrected QT interval and the QT-heart rate relation in families with genotypically characterized long QT syndrome. J Am Coll Cardiol 29:93
Lepeschkin E (1956) Components of Q-T and Q-U intervals of the electrocardiogram in normals. J Appl Physiol 9:443
Levin ER (2002) Cellular functions of plasma membrane estrogen receptors. Steroids 67:471
Liu K, Ballew C, Jacobs DR Jr, Sidney S, Savage PJ, Dyer A, Hughes G, Blanton MM (1989) Ethnic differences in blood pressure, pulse rate, and related characteristics in young adults. The CARDIA study. Hypertension 14:218
Liu S, Yuan S, Hertervig E, Kongstad O, Olsson SB (2001a) Gender and atrioventricular conduction properties of patients with symptomatic atrioventricular nodal reentrant tachycardia and Wolff–Parkinson–White syndrome. J Electrocardiol 34:295
Liu S, Yuan S, Kongstad O, Olsson SB (2001b) Gender differences in the electrophysiological characteristics of atrioventricular conduction system and their clinical implications. Scand Cardiovasc J 35:313
Liu XK, Katchman A, Drici MD, Ebert SN, Ducic I, Morad M, Woosley RL (1998a) Gender difference in the cycle length-dependent QT and potassium currents in rabbits. J Pharmacol Exp Ther 285:672
Liu XK, Katchman A, Ebert SN, Woosley RL (1998b) The antiestrogen tamoxifen blocks the delayed rectifier potassium current, IKr, in rabbit ventricular myocytes. J Pharmacol Exp Ther 287:877
Liu XK, Katchman A, Whitfield BH, Wan G, Janowski EM, Woosley RL, Ebert SN (2003) In vivo androgen treatment shortens the QT interval and increases the densities of inward and delayed rectifier potassium currents in orchiectomized male rabbits. Cardiovasc Res 57:28
Locati EH, Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Lehmann MH, Towbin JA, Priori SG, Napolitano C, Robinson JL, Andrews M, Timothy K, Hall WJ (1998) Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation 97:2237
Makkar RR, Fromm BS, Steinman RT, Meissner MD, Lehmann MH (1993) Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA 270:2590
Malkin CJ, Morris PD, Pugh PJ, English KM, Channer KS (2003) Effect of testosterone therapy on QT dispersion in men with heart failure. Am J Cardiol 92:1241
Marx SO, Kurokawa J, Reiken S, Motoike H, D’Armiento J, Marks AR, Kass RS (2002) Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science 295:496
Mayuga KA, Thattassery E, Taneja T, Karha J, Subacius H, Goldberger J, Kadish A (2010) Circadian and gender effects on repolarization in healthy adults: a study using harmonic regression analysis. Ann Noninvasive Electrocardiol 15:3
McDonnell DP, Norris JD (2002) Connections and regulation of the human estrogen receptor. Science 296:1642
McHugh NA, Cook SM, Schairer JL, Bidgoli MM, Merrill GF (1995) Ischemia- and reperfusion-induced ventricular arrhythmias in dogs: effects of estrogen. Am J Physiol 268:H2569
McKenna NJ, O’Malley BW (2002) Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108:465
Mendelsohn ME, Karas RH (2005) Molecular and cellular basis of cardiovascular gender differences. Science 308:1583
Merri M, Benhorin J, Alberti M, Locati E, Moss AJ (1989) Electrocardiographic quantitation of ventricular repolarization. Circulation 80:1301
Moran VH, Leathard HL, Coley J (2000) Cardiovascular functioning during the menstrual cycle. Clin Physiol 20:496
Moss AJ, Schwartz PJ, Crampton RS, Tzivoni D, Locati EH, MacCluer J, Hall WJ, Weitkamp L, Vincent GM, Garson A Jr et al (1991) The long QT syndrome. Prospective longitudinal study of 328 families. Circulation 84:1136
Murad F (1986) Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Invest 78:1
Murad F (2006) Shattuck Lecture. Nitric oxide and cyclic GMP in cell signaling and drug development. N Engl J Med 355:2003
Nakagawa M, Ooie T, Ou B, Ichinose M, Takahashi N, Hara M, Yonemochi H, Saikawa T (2005) Gender differences in autonomic modulation of ventricular repolarization in humans. J Cardiovasc Electrophysiol 16:278
Nakagawa M, Ooie T, Takahashi N, Taniguchi Y, Anan F, Yonemochi H, Saikawa T (2006) Influence of menstrual cycle on QT interval dynamics. Pacing Clin Electrophysiol 29:607
Nakagawa M, Sekine Y, Ono M, Taniguchi Y, Takahashi N, Yonemochi H, Saikawa T (2009) Gender differences in the effect of auditory stimuli on ventricular repolarization in healthy subjects. J Cardiovasc Electrophysiol 20:653
Nakagawa M, Takahashi N, Watanabe M, Ichinose M, Nobe S, Yonemochi H, Ito M, Saikawa T (2003) Gender differences in ventricular repolarization: terminal T wave interval was shorter in women than in men. Pacing Clin Electrophysiol 26:59
Nakajima T, Iwasawa K, Oonuma H, Morita T, Goto A, Wang Y, Hazama H (1999) Antiarrhythmic effect and its underlying ionic mechanism of 17beta-estradiol in cardiac myocytes. Br J Pharmacol 127:429
Nakamura H, Kurokawa J, Bai CX, Asada K, Xu J, Oren RV, Zhu ZI, Clancy CE, Isobe M, Furukawa T (2007) Progesterone regulates cardiac repolarization through a nongenomic pathway: an in vitro patch-clamp and computational modeling study. Circulation 116:2913
Nattel S (2011) From guidelines to bench: implications of unresolved clinical issues for basic investigations of atrial fibrillation mechanisms. Can J Cardiol 27:19
Nerbonne JM, Kass RS (2005) Molecular physiology of cardiac repolarization. Physiol Rev 85:1205
Node K, Kitakaze M, Kosaka H, Minamino T, Funaya H, Hori M (1997) Amelioration of ischemia- and reperfusion-induced myocardial injury by 17beta-estradiol: role of nitric oxide and calcium-activated potassium channels. Circulation 96:1953
Otsuki M, Gao H, Dahlman-Wright K, Ohlsson C, Eguchi N, Urade Y, Gustafsson JA (2003) Specific regulation of lipocalin-type prostaglandin D synthase in mouse heart by estrogen receptor beta. Mol Endocrinol 17:1844
Pham TV, Robinson RB, Danilo P Jr, Rosen MR (2002a) Effects of gonadal steroids on gender-related differences in transmural dispersion of L-type calcium current. Cardiovasc Res 53:752
Pham TV, Rosen MR (2002) Sex, hormones, and repolarization. Cardiovasc Res 53:740
Pham TV, Sosunov EA, Anyukhovsky EP, Danilo P Jr, Rosen MR (2002b) Testosterone diminishes the proarrhythmic effects of dofetilide in normal female rabbits. Circulation 106:2132
Pham TV, Sosunov EA, Gainullin RZ, Danilo P Jr, Rosen MR (2001) Impact of sex and gonadal steroids on prolongation of ventricular repolarization and arrhythmias induced by I(K)-blocking drugs. Circulation 103:2207
Rautaharju PM, Zhou SH, Wong S, Calhoun HP, Berenson GS, Prineas R, Davignon A (1992) Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol 8:690
Regitz-Zagrosek V (2006) Therapeutic implications of the gender-specific aspects of cardiovascular disease. Nat Rev Drug Discov 5:425
Rodriguez I, Kilborn MJ, Liu XK, Pezzullo JC, Woosley RL (2001) Drug-induced QT prolongation in women during the menstrual cycle. JAMA 285:1322
Rodriguez LM, de Chillou C, Schlapfer J, Metzger J, Baiyan X, van den Dool A, Smeets JL, Wellens HJ (1992) Age at onset and gender of patients with different types of supraventricular tachycardias. Am J Cardiol 70:1213
Rosano GM, Leonardo F, Sarrel PM, Beale CM, De Luca F, Collins P (1996) Cyclical variation in paroxysmal supraventricular tachycardia in women. Lancet 347:786
Rosenfeld CS, Wagner JS, Roberts RM, Lubahn DB (2001) Intraovarian actions of oestrogen. Reproduction 122:215
Rosenkranz-Weiss P, Tomek RJ, Mathew J, Eghbali M (1994) Gender-specific differences in expression of mRNAs for functional and structural proteins in rat ventricular myocardium. J Mol Cell Cardiol 26:261
Saraiva RM, Hare JM (2006) Nitric oxide signaling in the cardiovascular system: implications for heart failure. Curr Opin Cardiol 21:221
Satoh Y, Sugiyama A, Tamura K, Hashimoto K (2000) Effects of mexiletine on the canine cardiovascular system complicating cisapride overdose: potential utility of mexiletine for the treatment of drug-induced long QT syndrome. Jpn J Pharmacol 83:327
Savelieva I, Kakouros N, Kourliouros A, Camm AJ (2011) Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention. Europace 13:610
Schwartz JB (2003) Gender-specific implications for cardiovascular medication use in the elderly optimizing therapy for older women. Cardiol Rev 11:275
Sellers MB, Newby LK (2011) Atrial fibrillation, anticoagulation, fall risk, and outcomes in elderly patients. Am Heart J 161:241
Selye H (1942) Correlations between the chemical structure and the pharmacological actions of the steroids. Endocrinology 30:437
Seth R, Moss AJ, McNitt S, Zareba W, Andrews ML, Qi M, Robinson JL, Goldenberg I, Ackerman MJ, Benhorin J, Kaufman ES, Locati EH, Napolitano C, Priori SG, Schwartz PJ, Towbin JA, Vincent GM, Zhang L (2007) Long QT syndrome and pregnancy. J Am Coll Cardiol 49:1092
Shimizu W, Matsuo K, Kokubo Y, Satomi K, Kurita T, Noda T, Nagaya N, Suyama K, Aihara N, Kamakura S, Inamoto N, Akahoshi M, Tomoike H (2007) Sex hormone and gender difference–role of testosterone on male predominance in Brugada syndrome. J Cardiovasc Electrophysiol 18:415
Smetana P, Batchvarov VN, Hnatkova K, Camm AJ, Malik M (2002) Sex differences in repolarization homogeneity and its circadian pattern. Am J Physiol Heart Circ Physiol 282:H1889
Storstein L, Bjornstad H, Hals O, Meen HD (1991) Electrocardiographic findings according to sex in athletes and controls. Cardiology 79:227
Stramba-Badiale M, Spagnolo D, Bosi G, Schwartz PJ (1995) Are gender differences in QTc present at birth? MISNES investigators. Multicenter Italian Study on Neonatal Electrocardiography and Sudden Infant Death Syndrome. Am J Cardiol 75:1277
Tada H, Sticherling C, Chough SP, Baker RL, Wasmer K, Daoud EG, Oral H, Pelosi F Jr, Knight BP, Strickberger SA, Morady F (2001) Gender and age differences in induced atrial fibrillation. Am J Cardiol 88:436
Takahara A, Nakamura H, Nouchi H, Tamura T, Tanaka T, Shimada H, Tamura M, Tsuruoka N, Takeda K, Tanaka H, Shigenobu K, Hashimoto K, Sugiyama A (2007) Analysis of arrhythmogenic profile in a canine model of chronic atrioventricular block by comparing in vitro effects of the class III antiarrhythmic drug nifekalant on the ventricular action potential indices between normal heart and atrioventricular block heart. J Pharmacol Sci 103:181
Tamargo J (2000) Drug-induced torsade de pointes: from molecular biology to bedside. Jpn J Pharmacol 83:1
Tanabe S, Hata T, Hiraoka M (1999) Effects of estrogen on action potential and membrane currents in guinea pig ventricular myocytes. Am J Physiol 277:H826
Tanaka E (1999) Gender-related differences in pharmacokinetics and their clinical significance. J Clin Pharm Ther 24:339
Taneja T, Larsen J, Goldberger J, Kadish A (2001) Age, gender, and autonomic tone effects on surface electrocardiographic indices of ventricular repolarization. Ann Noninvasive Electrocardiol 6:290
Teplitz L, Igic R, Berbaum ML, Schwertz DW (2005) Sex differences in susceptibility to epinephrine-induced arrhythmias. J Cardiovasc Pharmacol 46:548
Topaz O, Castellanos A, Grobman LR, Myerburg RJ (1988) The role of arrhythmogenic auditory stimuli in sudden cardiac death. Am Heart J 116:222
Tran H, White CM, Chow MS, Kluger J (2001) An evaluation of the impact of gender and age on QT dispersion in healthy subjects. Ann Noninvasive Electrocardiol 6:129
Tse HF, Oral H, Pelosi F, Knight BP, Strickberger SA, Morady F (2001) Effect of gender on atrial electrophysiologic changes induced by rapid atrial pacing and elevation of atrial pressure. J Cardiovasc Electrophysiol 12:986
Verkerk AO, Wilders R, Veldkamp MW, de Geringel W, Kirkels JH, Tan HL (2005) Gender disparities in cardiac cellular electrophysiology and arrhythmia susceptibility in human failing ventricular myocytes. Int Heart J 46:1105
Wakili R, Voigt N, Kaab S, Dobrev D, Nattel S (2010) Recent advances in the molecular pathophysiology of atrial fibrillation. J Clin Invest 121:2955
Wilde AA, Antzelevitch C, Borggrefe M, Brugada J, Brugada R, Brugada P, Corrado D, Hauer RN, Kass RS, Nademanee K, Priori SG, Towbin JA (2002) Proposed diagnostic criteria for the Brugada syndrome: consensus report. Circulation 106:2514
Wysowski DK, Corken A, Gallo-Torres H, Talarico L, Rodriguez EM (2001) Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions. Am J Gastroenterol 96:1698
Xiao L, Zhang L, Han W, Wang Z, Nattel S (2006) Sex-based transmural differences in cardiac repolarization and ionic-current properties in canine left ventricles. Am J Physiol Heart Circ Physiol 291:H570
Yang PC, Clancy CE (2010) Effects of sex hormones on cardiac repolarization. J Cardiovasc Pharmacol 56:123
Yang PC, Kurokawa J, Furukawa T, Clancy CE (2010) Acute effects of sex steroid hormones on susceptibility to cardiac arrhythmias: a simulation study. PLoS Comput Biol 6:e1000658
Zareba W, Moss AJ, Locati EH, Lehmann MH, Peterson DR, Hall WJ, Schwartz PJ, Vincent GM, Priori SG, Benhorin J, Towbin JA, Robinson JL, Andrews ML, Napolitano C, Timothy K, Zhang L, Medina A (2003) Modulating effects of age and gender on the clinical course of long QT syndrome by genotype. J Am Coll Cardiol 42:103
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kurokawa, J., Kodama, M., Furukawa, T., Clancy, C.E. (2013). Sex and Gender Aspects in Antiarrhythmic Therapy. In: Regitz-Zagrosek, V. (eds) Sex and Gender Differences in Pharmacology. Handbook of Experimental Pharmacology, vol 214. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-30726-3_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-30726-3_12
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-30725-6
Online ISBN: 978-3-642-30726-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)